{"questions":[{"id":"open_question-4d560628-204c-44cf-853e-461357a414db","artifact_type":"open_question","title":"How do tanycytes interact with pathology?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:48.171079+00:00","updated_at":"2026-04-26T03:29:48.171079+00:00"},{"id":"open_question-9db7cdbb-a80d-4543-8801-bf8ed228f856","artifact_type":"open_question","title":"What drives tanycyte senescence?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:48.117036+00:00","updated_at":"2026-04-26T03:29:48.117036+00:00"},{"id":"open_question-41858ce0-166c-460e-9461-bff9ca862b7d","artifact_type":"open_question","title":"Can tanycyte function be restored?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:48.060293+00:00","updated_at":"2026-04-26T03:29:48.060293+00:00"},{"id":"open_question-d458505e-2fae-4130-a341-33c4ce8fecba","artifact_type":"open_question","title":"How does VTA pathology interact with cortical and limbic Lewy body pathology?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:39.318702+00:00","updated_at":"2026-04-26T03:29:39.318702+00:00"},{"id":"open_question-2885548b-4d7a-4b0e-8e33-e40beca3c97d","artifact_type":"open_question","title":"Can we develop therapies that selectively protect or restore VTA function?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:39.202588+00:00","updated_at":"2026-04-26T03:29:39.202588+00:00"},{"id":"open_question-b3a531f7-cbae-4079-a6a4-28002014b42c","artifact_type":"open_question","title":"How does VTA pathology contribute to specific non-motor symptoms?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:39.142579+00:00","updated_at":"2026-04-26T03:29:39.142579+00:00"},{"id":"open_question-456cdc6c-d661-41c6-a872-8ea9399a4df8","artifact_type":"open_question","title":"How does α-synuclein cause granule cell loss?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:37.811820+00:00","updated_at":"2026-04-26T03:29:37.811820+00:00"},{"id":"open_question-cell-types-crh-neurons-stress-v2-da3ed3cc","artifact_type":"open_question","title":"CRHR1 polymorphisms","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-crh-neurons-stress-v2-35e3cbbf","artifact_type":"open_question","title":"Epigenetic markers","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-ad26de8f-6e24-4371-8614-3d86c073907b","artifact_type":"open_question","title":"Can pharmacological approaches enhance AAC function?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:26.374411+00:00","updated_at":"2026-04-26T03:29:26.374411+00:00"},{"id":"open_question-ffe88a19-ddde-4464-9e2a-9d69982bac19","artifact_type":"open_question","title":"What defines selective vulnerability of MS GABAergic neurons?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:43.031405+00:00","updated_at":"2026-04-26T03:28:43.031405+00:00"},{"id":"open_question-c7bd6442-3ae0-4c3c-8e00-75f955b34a40","artifact_type":"open_question","title":"What are the molecular mechanisms of cuneate plasticity?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:26:36.781723+00:00","updated_at":"2026-04-26T03:26:36.781723+00:00"},{"id":"open_question-d6d658dd-2da8-4691-b58f-668a4e666a78","artifact_type":"open_question","title":"What are the precise circuit functions of different X94-like subpopulations?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:16.818226+00:00","updated_at":"2026-04-26T03:29:16.818226+00:00"},{"id":"open_question-c242afed-02ed-450e-8d70-f070873a1208","artifact_type":"open_question","title":"Can ENS biopsy serve as a definitive diagnostic tool?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:20.991879+00:00","updated_at":"2026-04-26T03:28:20.991879+00:00"},{"id":"open_question-e3dcdd80-e37c-4b0f-ae07-73e5e53d798a","artifact_type":"open_question","title":"What is the temporal relationship between cerebellar and cortical pathology?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:50.218068+00:00","updated_at":"2026-04-26T03:25:50.218068+00:00"},{"id":"open_question-2398e8a9-de73-4475-b7db-f39a83ce2364","artifact_type":"open_question","title":"How does BNST pathology interact with other brain regions in neurodegeneration?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:50.827930+00:00","updated_at":"2026-04-26T03:25:50.827930+00:00"},{"id":"open_question-f09edbae-3639-4c5d-8027-a64b95df65cd","artifact_type":"open_question","title":"What is the temporal relationship between BNST dysfunction and cognitive decline?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:51.021342+00:00","updated_at":"2026-04-26T03:25:51.021342+00:00"},{"id":"open_question-5fed1683-cb6c-4866-a1d9-c421528d6676","artifact_type":"open_question","title":"Does kainate receptor dysfunction precede amyloid pathology in the hippocampus?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:56.153902+00:00","updated_at":"2026-04-26T03:28:56.153902+00:00"},{"id":"open_question-9156015c-94b0-4eb9-97ef-d909ccfeb201","artifact_type":"open_question","title":"Can AIS be protected or regenerated after injury?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:52.979627+00:00","updated_at":"2026-04-26T03:27:52.979627+00:00"},{"id":"open_question-4a883ee0-c541-4cf8-b893-8d60d82282f4","artifact_type":"open_question","title":"Which molecular signatures distinguish NRM subpopulations that bias toward facilitation versus inhibition in chronic disease?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:55.895772+00:00","updated_at":"2026-04-26T03:25:55.895772+00:00"},{"id":"open_question-cd2308f1-2d90-4f5c-b384-a1f7dd28203e","artifact_type":"open_question","title":"Can early raphe biomarker shifts identify PD subgroups at risk for severe pain and autonomic instability?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:55.966783+00:00","updated_at":"2026-04-26T03:25:55.966783+00:00"},{"id":"open_question-e48d3490-b40d-4717-9d56-a547fe5e2548","artifact_type":"open_question","title":"Does AD pathology originate in olfactory structures including EpN?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:56.100947+00:00","updated_at":"2026-04-26T03:27:56.100947+00:00"},{"id":"open_question-61bf6662-f1ac-47ab-9d1b-33907f2a5765","artifact_type":"open_question","title":"Can early multimodal biomarkers reliably predict CBS underlying pathology before severe disability?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:26:30.133501+00:00","updated_at":"2026-04-26T03:26:30.133501+00:00"},{"id":"open_question-c72d6a24-c888-4a14-89b6-cc1626569ece","artifact_type":"open_question","title":"Can NPY/AgRP-targeting therapies improve metabolic outcomes in AD/PD without disrupting normal energy homeostasis?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:50.524738+00:00","updated_at":"2026-04-26T03:29:50.524738+00:00"},{"id":"open_question-40eea346-b7bf-48c9-90f2-f12e7bb20462","artifact_type":"open_question","title":"Does early tau or α-synuclein pathology in the hypothalamus directly dysregulate NPY/AgRP neurons?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:50.447557+00:00","updated_at":"2026-04-26T03:29:50.447557+00:00"},{"id":"open_question-48d6da6e-28cb-4721-9861-db0a79f1eb16","artifact_type":"open_question","title":"What is the relationship between VTA dysfunction and prodromal PD markers?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:39.263232+00:00","updated_at":"2026-04-26T03:29:39.263232+00:00"},{"id":"open_question-57bcfa2a-14dc-487b-9913-395cf126d64b","artifact_type":"open_question","title":"What are the precise molecular mechanisms conferring relative neuroprotection?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:39.087285+00:00","updated_at":"2026-04-26T03:29:39.087285+00:00"},{"id":"open_question-1dfc8462-6e7b-47f3-bea0-26994462f13a","artifact_type":"open_question","title":"What makes granule cells specifically vulnerable in MSA?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:37.751010+00:00","updated_at":"2026-04-26T03:29:37.751010+00:00"},{"id":"open_question-55b07b98-a397-4f21-97c2-0a5a2d6c72b5","artifact_type":"open_question","title":"How do we balance barrier protection with drug delivery?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:37.462885+00:00","updated_at":"2026-04-26T03:29:37.462885+00:00"},{"id":"open_question-17153a0a-1a74-43e5-89ca-f91ad360540e","artifact_type":"open_question","title":"What is the optimal combination of barrier modulators?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:37.405225+00:00","updated_at":"2026-04-26T03:29:37.405225+00:00"},{"id":"open_question-a2a38885-4a88-4d62-a4ae-068ab9fbb347","artifact_type":"open_question","title":"Can we develop biomarkers predicting barrier breakdown?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:37.354382+00:00","updated_at":"2026-04-26T03:29:37.354382+00:00"},{"id":"open_question-55e21a3f-3ecf-4bab-9d7c-50334ae43b78","artifact_type":"open_question","title":"How does the BBB change in prodromal disease stages?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:37.298697+00:00","updated_at":"2026-04-26T03:29:37.298697+00:00"},{"id":"open_question-cell-types-ventral-cochlear-nucleus-anterior-9d0343bd","artifact_type":"open_question","title":"Two-photon imaging","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-ventral-cochlear-nucleus-anterior-fcfbb8da","artifact_type":"open_question","title":"Single-cell RNA sequencing","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-ventral-cochlear-nucleus-anterior-ed84db1a","artifact_type":"open_question","title":"Advanced MRI","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-spatial-omics-neurons-ce35e7fd","artifact_type":"open_question","title":"Single-cell","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-85cb3d45-929e-46b1-8641-e8e2b28f6702","artifact_type":"open_question","title":"Personalized approaches**: How do individual differences in ZI circuit function influence disease progression?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:29.565280+00:00","updated_at":"2026-04-26T03:29:29.565280+00:00"},{"id":"open_question-7d03ee55-88f4-4875-acc1-65300b9f07fa","artifact_type":"open_question","title":"Circuit-specific dysfunction**: How do specific ZI circuits contribute to different symptoms in neurodegeneration?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:29.310958+00:00","updated_at":"2026-04-26T03:29:29.310958+00:00"},{"id":"open_question-77f110c7-2687-4202-8dcf-ac78502dc030","artifact_type":"open_question","title":"How do genetic risk factors affect AACs?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:26.291296+00:00","updated_at":"2026-04-26T03:29:26.291296+00:00"},{"id":"open_question-f87f88d2-1b82-43b0-a9ee-1571a4fdb7fe","artifact_type":"open_question","title":"How do AACs contribute to hippocampal memory encoding?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:26.058668+00:00","updated_at":"2026-04-26T03:29:26.058668+00:00"},{"id":"open_question-b6eb51e4-6a90-4a1d-a93a-abedc922d952","artifact_type":"open_question","title":"Which VGLUT-defined subpopulations are most resilient, and what molecular programs confer that resilience?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:19.400279+00:00","updated_at":"2026-04-26T03:29:19.400279+00:00"},{"id":"open_question-701f1c57-bcda-485c-9a42-789bf106b592","artifact_type":"open_question","title":"When does VGLUT remodeling shift from adaptive plasticity to maladaptive excitotoxic pressure in AD and PD?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:19.341369+00:00","updated_at":"2026-04-26T03:29:19.341369+00:00"},{"id":"open_question-09883de2-4e48-434f-a23b-79c66bb0c359","artifact_type":"open_question","title":"Are there cell replacement therapies for TL cell loss?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:34.231379+00:00","updated_at":"2026-04-26T03:29:34.231379+00:00"},{"id":"open_question-63e00b03-bef0-496a-9113-8c9a75a12040","artifact_type":"open_question","title":"What pharmacological targets modulate TL cell activity?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:34.171950+00:00","updated_at":"2026-04-26T03:29:34.171950+00:00"},{"id":"open_question-22e6b089-a9d1-4e25-bc03-20e8dad5f65c","artifact_type":"open_question","title":"Can optogenetic or chemogenetic approaches restore TL function?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:34.110300+00:00","updated_at":"2026-04-26T03:29:34.110300+00:00"},{"id":"open_question-6256be02-22f7-41b4-a2ed-e8852cd4098f","artifact_type":"open_question","title":"What developmental programs specify TL cell fate and connectivity?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:33.929312+00:00","updated_at":"2026-04-26T03:29:33.929312+00:00"},{"id":"open_question-c51eae49-70d9-4137-8800-216bfa69423b","artifact_type":"open_question","title":"How should asymmetric pallidal injury be incorporated into trial stratification frameworks?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:31.875511+00:00","updated_at":"2026-04-26T03:29:31.875511+00:00"},{"id":"open_question-3dc227fe-adae-41d0-b5a4-66e2e487fb73","artifact_type":"open_question","title":"Which pallidal microstructural features best track progression in CBD versus PSP-corticobasal phenotypes?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:31.656797+00:00","updated_at":"2026-04-26T03:29:31.656797+00:00"},{"id":"open_question-7c1d6fa7-32ef-49ef-8a2d-4ddceca9050e","artifact_type":"open_question","title":"Do anti-tau interventions measurably alter pallidal-thalamic circuit metrics before global scales change?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:31.801758+00:00","updated_at":"2026-04-26T03:29:31.801758+00:00"},{"id":"open_question-9d53d40e-f4b7-4e58-a647-01c427dd3efb","artifact_type":"open_question","title":"Can pallidal network signatures predict response to targeted rehabilitation or botulinum toxin strategies?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:31.722574+00:00","updated_at":"2026-04-26T03:29:31.722574+00:00"},{"id":"open_question-0dd177e4-7c5b-4b16-be31-ceb882206507","artifact_type":"open_question","title":"How do environmental factors interact with mutations?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:30.593869+00:00","updated_at":"2026-04-26T03:29:30.593869+00:00"},{"id":"open_question-a4b2fee0-aff8-4a48-b112-46f02c5090bc","artifact_type":"open_question","title":"Can sporadic PD involve PINK1 pathway dysfunction?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:30.509998+00:00","updated_at":"2026-04-26T03:29:30.509998+00:00"},{"id":"open_question-cell-types-alpha-1-adrenergic-receptor-neurons-fa84de09","artifact_type":"open_question","title":"Cell-type specific targeting","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-alpha-1-adrenergic-receptor-neurons-86748f9a","artifact_type":"open_question","title":"Temporal dynamics","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-alpha-1-adrenergic-receptor-neurons-49402d63","artifact_type":"open_question","title":"Combination therapies","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-cno-dreads-neurons-035d0d45","artifact_type":"open_question","title":"Clinical translation","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-cno-dreads-neurons-334e8430","artifact_type":"open_question","title":"[Gene therapy](/therapeutics/gene-therapy-neurodegeneration)","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-axon-initial-segment-neurod-836cfc66","artifact_type":"open_question","title":"Mechanistic understanding","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-drg-chronic-pain-964b70af","artifact_type":"open_question","title":"Mitochondrial function","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-drg-chronic-pain-9908e593","artifact_type":"open_question","title":"Satellite glial cells","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-schwann-cell-precursors-1fac1736","artifact_type":"open_question","title":"Single-Cell Sequencing","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-9b85d703-462c-4119-9923-d8ffcc07db5d","artifact_type":"open_question","title":"Does D2-MSN dysfunction precede motor symptoms in prodromal PD?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:47.330567+00:00","updated_at":"2026-04-26T03:25:47.330567+00:00"},{"id":"open_question-9f4c8d1c-7397-4215-9acf-a49117f4cc28","artifact_type":"open_question","title":"Can PDE10A inhibitors provide neuroprotection beyond symptomatic relief?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:47.405973+00:00","updated_at":"2026-04-26T03:25:47.405973+00:00"},{"id":"open_question-b8b1a8c4-87bc-4817-8dcf-0d280ec561d9","artifact_type":"open_question","title":"What makes granule neurons selectively vulnerable?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:49.826285+00:00","updated_at":"2026-04-26T03:25:49.826285+00:00"},{"id":"open_question-5c201189-e6ea-46c2-b53f-706b3a451f3e","artifact_type":"open_question","title":"How does cerebellar pathology contribute to cognitive decline?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:49.950800+00:00","updated_at":"2026-04-26T03:25:49.950800+00:00"},{"id":"open_question-cdebc8d4-0e32-40ed-99e2-70365900ec39","artifact_type":"open_question","title":"Can cerebellar function be restored in established disease?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:50.082702+00:00","updated_at":"2026-04-26T03:25:50.082702+00:00"},{"id":"open_question-77646b95-772a-4cf6-a25f-ce331405d62a","artifact_type":"open_question","title":"Can BNST-targeted interventions slow disease progression?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:50.925727+00:00","updated_at":"2026-04-26T03:25:50.925727+00:00"},{"id":"open_question-cell-types-lysosomal-impaired-neurons-8abd73c0","artifact_type":"open_question","title":"GBA gene delivery","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-glial-cell-line-derived-neurotrophic-factor-neurons-940eac5d","artifact_type":"open_question","title":"Delivery optimization","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-glial-cell-line-derived-neurotrophic-factor-neurons-8097bce4","artifact_type":"open_question","title":"Engineered GDNF variants","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-glial-cell-line-derived-neurotrophic-factor-neurons-3b82e104","artifact_type":"open_question","title":"Combination therapy","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-ventral-cochlear-nucleus-anterior-070551a2","artifact_type":"open_question","title":"Optogenetics","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-spatial-omics-neurons-021b20f5","artifact_type":"open_question","title":"Multi-omics","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-medial-septo-hippocampal-gabaergic-1fac1736","artifact_type":"open_question","title":"Single-Cell Sequencing","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-medial-septo-hippocampal-gabaergic-13e248d9","artifact_type":"open_question","title":"Circuit Mapping","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-medial-septo-hippocampal-gabaergic-df6c7020","artifact_type":"open_question","title":"Therapeutic Development","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-medial-septo-hippocampal-gabaergic-f9c8f85d","artifact_type":"open_question","title":"Biomarker Development","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-crh-neurons-stress-v2-2f11c5fd","artifact_type":"open_question","title":"FKBP5 genotyping","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-crh-neurons-stress-v2-c041a66d","artifact_type":"open_question","title":"CRH neuron-specific delivery","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-crh-neurons-stress-v2-cc8a8152","artifact_type":"open_question","title":"Allopregnanolone modulation","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-crh-neurons-stress-v2-fd347d43","artifact_type":"open_question","title":"Vagus nerve stimulation","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-crh-neurons-stress-v2-078eea22","artifact_type":"open_question","title":"Oxytocin augmentation","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-alpha-1-adrenergic-receptor-neurons-4c5bef16","artifact_type":"open_question","title":"Subtype-specific signaling","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-cno-dreads-neurons-49402d63","artifact_type":"open_question","title":"Combination therapies","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-cno-dreads-neurons-11a4bc8f","artifact_type":"open_question","title":"Application to [tauopathies](/mechanisms/tauopathies) and [synucleinopathies](/mechanisms/synucleinopathies)","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-globus-pallidus-pkan-88d0ca18","artifact_type":"open_question","title":"Gene therapy","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-globus-pallidus-pkan-4d788f37","artifact_type":"open_question","title":"CoA pathway modulators","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-globus-pallidus-pkan-3a95bc9a","artifact_type":"open_question","title":"Iron metabolism","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-globus-pallidus-pkan-81cf799c","artifact_type":"open_question","title":"Clinical trials","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-axon-initial-segment-neurod-29081d9b","artifact_type":"open_question","title":"Early detection","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-axon-initial-segment-neurod-c5dcf2c4","artifact_type":"open_question","title":"Therapeutic targeting","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-nts-expanded-364c60e6","artifact_type":"open_question","title":"Mechanistic Understanding","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-nts-expanded-f9c8f85d","artifact_type":"open_question","title":"Biomarker Development","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-nts-expanded-df6c7020","artifact_type":"open_question","title":"Therapeutic Development","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-drg-chronic-pain-4a8fb770","artifact_type":"open_question","title":"Genetic profiling","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-drg-chronic-pain-b5dffb96","artifact_type":"open_question","title":"Phenotyping","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-drg-chronic-pain-be42024e","artifact_type":"open_question","title":"Biomarker panels","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-drg-chronic-pain-bc359a22","artifact_type":"open_question","title":"Immune modulation","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-cell-types-drg-chronic-pain-92d6d8d2","artifact_type":"open_question","title":"Epigenetic therapy","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-8ac1d83d-d5d7-4707-ae73-5e76ef7ba846","artifact_type":"open_question","title":"Can we target tanycytes therapeutically?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:48.226174+00:00","updated_at":"2026-04-26T03:29:48.226174+00:00"}],"total":501,"limit":100,"offset":0,"returned":100,"sort":"importance_elo","field":"cell"}